Omokawa Shohei, Imaeda Toshihiko, Sawaizumi Takuya, Momose Toshimitsu, Gotani Hiroyuki, Abe Yukio, Moritomo Hisao, Kanaya Fuminori
Department of Orthopaedic Surgery, Nara Medical University, Kashihara, Japan.
J Orthop Sci. 2012 Sep;17(5):551-5. doi: 10.1007/s00776-012-0265-1. Epub 2012 Jul 19.
We evaluated the responsiveness of patient-derived questionnaires and physical findings in evaluating recovery after treatment of ulnocarpal abutment syndrome.
Patients were assessed at their initial visit to our clinic and again 3 months after the treatment. At each visit, patients completed a Short Form-36, the Japanese Society for Surgery of the Hand version of Disability of the Arm, Shoulder, and Hand questionnaire (DASH-JSSH), and the Japanese version of patient-rated wrist evaluation (PRWE-J). Grip strength, range of motion, and visual analogue scale for wrist pain were also examined at each visit. Satisfaction with treatment was questioned after 3 months using a Likert scale. Standardized response means (SRM) and effect sizes were calculated to evaluate the responsiveness.
The PRWE-J (SRM, 1.35) was the most responsive questionnaire, followed by the DASH-JSSH (SRM, 0.81) and the Short Form-36 (SRM, -0.38 to -1.19). Of the physical tests, grip strength (SRM, 0.81) was more responsive than range of motion (SRM, 0.01 to -0.29). The visual analogue pain scale (SRM, 1.56) was highly responsive. Changes in the PRWE score were correlated with the satisfaction rating for the treatment.
Responsive patient-derived scales can assist in the outcome evaluation of patients with ulnocarpal abutment syndrome.
我们评估了患者自评问卷和体格检查结果在评估尺腕撞击综合征治疗后恢复情况方面的反应性。
在患者首次就诊于我们诊所时以及治疗后3个月再次对其进行评估。每次就诊时,患者均需完成一份简明健康状况调查问卷(Short Form-36)、日本手部外科学会版的手臂、肩部和手部功能障碍问卷(DASH-JSSH)以及日本版患者自评腕关节评估问卷(PRWE-J)。每次就诊时还会检查握力、活动范围以及腕部疼痛视觉模拟量表。3个月后使用李克特量表询问患者对治疗的满意度。计算标准化反应均值(SRM)和效应量以评估反应性。
PRWE-J(SRM,1.35)是反应性最强的问卷,其次是DASH-JSSH(SRM,0.81)和简明健康状况调查问卷(SRM,-0.38至-1.19)。在体格检查中,握力(SRM,0.81)比活动范围(SRM,0.01至-0.29)反应性更强。视觉模拟疼痛量表(SRM,1.56)反应性很高。PRWE评分的变化与治疗满意度评分相关。
反应性强的患者自评量表有助于评估尺腕撞击综合征患者的治疗结果。